|Bid||0.6300 x 0|
|Ask||0.6400 x 0|
|Day's range||0.6100 - 0.6400|
|52-week range||0.5600 - 1.9900|
|Beta (5Y monthly)||2.97|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
In recent years, Aurora Cannabis (NASDAQ: ACB) has been trying to slash expenses wherever it could to improve its cash flow and bottom line. This has included closing facilities, cutting staff, and ultimately reducing its position in the consumer cannabis market in Canada. The efforts have been paying off, as the company has posted stronger results of late, including positive adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) for four consecutive quarters.
The last five years have been downright brutal for the cannabis industry. Pick a cannabis stock and you'll likely find a horrible investment to own during that stretch. Aurora Cannabis (NASDAQ: ACB) has gone from being a promising growth stock to an ultra-risky investment.
In this article, we discuss 11 best cannabis stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Cannabis Stocks To Buy Now. Cannabis, a flowering plant genus, boasts a rich history of utilization, primarily for its acknowledged therapeutic and medical benefits. Presently, over 52 million Americans […]